Submission of results for the quarter and year ended 31st March 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
CDG Petchem reported audited FY25 results showing a steep revenue decline, with standalone revenue from operations falling to Rs 898.73 lakhs from Rs 1,539.98 lakhs in FY24 (a drop of about 42%). The company posted a wider standalone loss after tax of Rs 105.75 lakhs versus Rs 91.64 lakhs in the previous year, with a Q4 standalone loss of Rs 23.87 lakhs. Consolidated results showed revenue falling to Rs 2,309.97 lakhs (from Rs 4,052.75 lakhs) and a loss of Rs 110.54 lakhs versus Rs 73.59 lakhs in FY24. Standalone net worth turned negative at Rs -20.63 lakhs (FY24 was Rs 85.12 lakhs) and consolidated equity is near zero, while consolidated operating cash flow turned sharply negative at Rs -721.51 lakhs compared with a positive Rs 114.19 lakhs in FY24. On a positive note, the company sharply reduced its qualified borrowings from Rs 7.02 crore to Rs 0.24 crore. The statutory auditor issued an unqualified opinion on both standalone and consolidated results.
Shareholders face a worrying picture: revenue is shrinking sharply, losses are widening, the company has effectively wiped out its standalone net worth, and operating cash flow has turned deeply negative — all red flags for the business even though debt has been paid down. The stock is likely to see a negative reaction given the weak operating performance, though the debt reduction provides some comfort.